• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Alli (orlistat) capsules

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

 

June 2014

Summary View

Drug Facts Label

Ask a doctor or pharmacist before use if you are

  • Taking medicine for seizures

Stop use and ask a doctor if

  • You are taking medicine for seizures and your seizures happen more often or get worse 

 

September 2010

Summary View 

WARNING

Stop use and ask a doctor if:
  • you develop itching
  • yellow eyes or skin
  • dark urine or loss of appetite
  • There have been rare reports of liver injury in people taking orlistat